Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is a safe and effective treatment for severe alopecia areata.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Baricitinib successfully treated severe hair loss.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

New compounds may help treat prostate issues without affecting androgen receptors.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

A rigid compound with a common structural motif was successfully synthesized.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The birth control pill containing ethinylestradiol and chlormadinone may help treat acne and other skin and hair conditions related to hormones.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Low alternating doses of sodium divalproate reduced migraine frequency but caused weight gain.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Imuvert can prevent some chemotherapy-induced hair loss.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.